Skip to main content
HOUSE 1316115th CongressReferred to the Subcommittee on Military Personnel.

Prescription Drug Price Transparency Act

Last Action
4/5/2017

Actions

  • 2017-04-05Referred to the Subcommittee on Military Personnel.
  • 2017-03-17Referred to the Subcommittee on Health.
  • 2017-03-15Referred to the Subcommittee on Health.
  • 2017-03-02Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, Armed Services, and Oversight and Government Reform, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  • 2017-03-02Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, Armed Services, and Oversight and Government Reform, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  • 2017-03-02Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, Armed Services, and Oversight and Government Reform, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  • 2017-03-02Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, Armed Services, and Oversight and Government Reform, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  • 2017-03-02Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, Armed Services, and Oversight and Government Reform, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  • 2017-03-02Introduced in House
  • 2017-03-02Introduced in House

CRS Summary

As of 2017-03-02 (00)

Prescription Drug Price Transparency Act

This bill adds certain transparency requirements for pharmacy benefits managers under Medicare, Medicare Advantage, TRICARE, and the Federal Employees Health Benefits Program.

Cosponsors (20)

  • David Loebsack (D-IA)
  • Earl Carter (R-GA)
  • JOHN DUNCAN (R-TN)
  • Cathy McMorris Rodgers (R-WA)
  • Rod Blum (R-IA)
  • John Sarbanes (D-MD)
  • Brian Babin (R-TX)
  • JAMES LANGEVIN (D-RI)
  • Robert Wittman (R-VA)
  • Rick Allen (R-GA)
  • ROBERT ADERHOLT (R-AL)
  • Austin Scott (R-GA)
  • Peter Welch (D-VT)
  • Mo Brooks (R-AL)
  • COLLIN PETERSON (D-MN)
  • ELIJAH CUMMINGS (D-MD)
  • Tom Graves (R-GA)
  • David Rouzer (R-NC)
  • Mike Rogers (R-AL)
  • Eric Crawford (R-AR)

Subjects

  • Administrative remedies
  • Consumer affairs
  • Contracts and agency
  • Government employee pay, benefits, personnel management
  • Health care costs and insurance
  • Health information and medical records
  • Insurance industry and regulation
  • Medical ethics
  • Medicare
  • Military medicine
  • Prescription drugs
  • Public contracts and procurement
  • Retail and wholesale trades
  • Right of privacy
Read on Congress.gov

Sourced from Congress.gov (public domain).

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.